ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $220,000 | -6.0% | 1,750 | -69.2% | 0.20% | +29.0% |
| Q2 2019 | $234,000 | -34.5% | 5,685 | -37.7% | 0.16% | +78.2% |
| Q1 2018 | $357,000 | -68.3% | 9,118 | -69.8% | 0.09% | -72.7% |
| Q3 2017 | $1,127,000 | +159.1% | 30,200 | +111.2% | 0.32% | +112.7% |
| Q2 2017 | $435,000 | -13.0% | 14,300 | -24.3% | 0.15% | -26.5% |
| Q1 2017 | $500,000 | – | 18,900 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |